title: Intracystic papillary carcinoma of the male breast: a case report and review of the literature.
abstract: BACKGROUND
  Carcinoma of the male breast is an infrequent and poorly understood disease (Sinha et al. in Ann R Coll Surg Engl 88(5):W3-W5, 2006). It differs from female breast cancer in both demographic and histopathological characteristics.
  
  
  METHODS
  Herein we describe a case of intracystic papillary carcinoma in situ in a male breast with a review of the literature.
  
  
  CONCLUSIONS
  Although rare, in situ carcinoma constitutes a larger proportion of male than female breast cancer in a non-screened population. It is characteristically of the papillary and micropapillary subtype. Intracystic papillary carcinoma is a noncomedo intraductal carcinoma constituting about 0.5% of female breast cancers and is associated with a slightly inferior prognosis than other noncomedo intraductal carcinomas (Lefkowitz et al. in Hum Pathol 25:802-809, 1994).
authors: Department of Surgery, University College Hospital, Galway, Ireland. drarshad8@yahoo.com
authors: A
authors: A
authors: Hussain
authors: K J
authors: KJ
authors: Sweeney
authors: R
authors: R
authors: Salman
authors: G M
authors: GM
authors: Callagy
authors: I
authors: I
authors: Sweeney
authors: R
authors: R
authors: McLaughlin
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D018567:Breast Neoplasms, Male / Q000188:drug therapy / Q000473:pathology* / Q000601:surgery*; D018270:Carcinoma, Ductal, Breast / Q000188:drug therapy / Q000473:pathology* / Q000601:surgery*; D017024:Chemotherapy, Adjuvant; D006801:Humans; D008297:Male; D008408:Mastectomy; D008875:Middle Aged; D013629:Tamoxifen / Q000627:therapeutic use
chemical_list: D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen